Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Already have an account? Login here
Categories // Subject Area // News
The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust (both London, UK) have investigated a new precision medicine, berzosertib, that targets cancer’s ability to repair its DNA.
It's completely free
Written ByRachel Jenkins, Future Science Group
Updated 24 June, 2020